WallStreetZenWallStreetZen

NASDAQ: CDXC
Chromadex Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CDXC past revenue growth

How has CDXC's revenue growth performed historically?
Company
15.99%
Industry
143.99%
Market
17.8%
CDXC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CDXC's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CDXC's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CDXC earnings and revenue history

Current Revenue
$83.6M
Current Earnings
-$4.9M
Current Profit Margin
-5.9%

CDXC Return on Equity

Current Company
-17.8%
Current Industry
-63.5%
Current Market
188%
CDXC's Return on Equity (-17.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CDXC announces earnings.

CDXC Return on Assets

Current Company
-9.2%
Current Industry
2.9%
CDXC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CDXC Return on Capital Employed

Current Company
-14.38%
Current Industry
19.5%
CDXC has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CDXC vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CDXC$83.57M-$3.23M-$4.94M+21.50%N/A
VNDA$192.64M$9.35M$2.51M-0.05%-39.66%
VTYX$0.00-$192.02M-$192.96MN/AN/A
AGEN$156.31M-$134.25M-$245.97M+33.56%N/A
INO$832.01k-$130.39M-$135.12M-51.33%N/A
View Top Biotech Stocks

CDXC earnings dates

Next earnings date
Jun 20, 2024

Chromadex Earnings & Revenue FAQ

What were CDXC's earnings last quarter?

On Invalid Date, Chromadex (NASDAQ: CDXC) reported Q4 2023 earnings per share (EPS) of $0.00, up 100% year over year. Total Chromadex earnings for the quarter were $114.00 thousand. In the same quarter last year, Chromadex's earnings per share (EPS) was -$0.02.

If you're new to stock investing, here's how to buy Chromadex stock.

What was CDXC's earnings growth in the past year?

As of Q2 2024, Chromadex's earnings has grown year over year. Chromadex's earnings in the past year totalled -$4.94 million.

What is CDXC's earnings date?

Chromadex's earnings date is Invalid Date. Add CDXC to your watchlist to be reminded of CDXC's next earnings announcement.

What was CDXC's revenue last quarter?

On Invalid Date, Chromadex (NASDAQ: CDXC) reported Q4 2023 revenue of $21.20 million up 0.95% year over year. In the same quarter last year, Chromadex's revenue was $21.00 million.

What was CDXC's revenue growth in the past year?

As of Q2 2024, Chromadex's revenue has grown 15.99% year over year. This is 128 percentage points lower than the US Biotechnology industry revenue growth rate of 143.99%. Chromadex's revenue in the past year totalled $83.57 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.